MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis
Journal of Pathology and Translational Medicine
;
: 249-256, 2015.
Article
in English
| WPRIM
| ID: wpr-188225
ABSTRACT
BACKGROUND:
While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinicopathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC).METHODS:
The present study investigated the correlation between MUC2 expression and clinicopathological parameters in 167 human GCs. In addition, to confirm the clinicopathological significance of MUC2 expression, we performed a systematic review and meta-analysis in 1,832 GCs.RESULTS:
MUC2 expression was found in 58 of 167 GCs (34.7%). MUC2-expressing GC showed lower primary tumor (T), regional lymph node (N), and tumor node metastasis (TNM) stages compared with GCs without MUC2 expression (p=.001, p=.001, and p=.011, respectively). However, MUC2 expression was not correlated with Lauren's classification and tumor differentiation. In meta-analysis, MUC2 expression was significantly correlated with differentiation and lower tumor stage (odds ratio [OR], 1.303; 95% confidence interval [CI], 1.020 to 1.664; p = .034 and OR, 1.352; 95% CI, 1.055 to 1.734; p = .017, respectively) but not with Lauren's classification, pN stage, or pTNM stage.CONCLUSIONS:
MUC2 expression was correlated with a lower tumor depth and lower lymph node metastasis in our study; the meta-analysis showed a correlation of MUC2 expression with tumor differentiation and lower tumor depth.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Classification
/
Lymph Nodes
/
Metaplasia
/
Neoplasm Metastasis
Type of study:
Systematic reviews
Limits:
Humans
Language:
English
Journal:
Journal of Pathology and Translational Medicine
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS